The interplay between medical devices and the expanded access to clinical data is strengthening diagnostics, procedures, and therapeutics. Additionally, the divisions between the medical device ecosystem and the worlds of pharmaceuticals, health care, and digital health are continually shrinking. Peter Fitzgerald and the illustrious members of this panel exemplify this innovation, and Deerfield Catalyst is proud to be a key player in this changing landscape and looks forward to the synergies that will emerge.
Featuring:
Steve Hochberg, partner at Deerfield Management
Howard Levin, Deerfield Catalyst
David Cassak, co-editor-in-chief and managing partner at MedTech Strategist
Peter Fitzgerald, director of the Center for Cardiovascular Technology at Stanford University
Susan Rosenthal, vice president, Life Sciences & Healthcare at New York City Economic Development Corporation
Brought to you by Cure by Deerfield
The Cure at 345 Park Avenue South, leading life science, digital health, and tech-enabled companies from across the world come together to uncover cutting-edge solutions for those in need. We provide laboratories, engineering and computing space, and other amenities and supportive services to help today’s thought leaders build a better tomorrow.